KELLER ERIC L. (Chief Executive Officer) purchased 5.2% of their position (20.80K shares) of RETENSION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $249.6K — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+20.80K
Price / share
$12.00
Trade value
$249.60K
% of position
Common Stock
Shares
+9.66K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+31.37K
Price / share
—
Trade value
—
% of position
Net shares
+61.83K
Net value
$249.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/13/2026 | P · Purchase | +20.80K | $12.00 | $249.60K | 5.2% | 402.58K | 423.38K |
| Common Stock Direct | 10/13/2026 | C · Conversion | +9.66K | — | — | 2.3% | 423.38K | 433.04K |
| Common Stock Direct | 10/13/2026 | C · Conversion | +31.37K | — | — | 7.2% | 433.04K | 464.41K |
| Total | +61.83K | $249.60K | ||||||
Stock Option (right to buy)
Common Stock
255.17K shares
Shares
+255.17K
Strike price
11.63
Held after
255.17K
Exercisable
—
Series A Convertible Preferred Stock
Common Stock
9.66K shares
Shares
−9.66K
Strike price
Held after
0.00
Exercisable
—
Series B Convertible Preferred Stock
Common Stock
31.37K shares
Shares
−31.37K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock255.17K shares | 10/13/2026 | A · Award | +255.17K | 11.63 | — | 255.17K |
| Series A Convertible Preferred Stock Direct | Common Stock9.66K shares | 10/13/2026 | C · Conversion | −9.66K | — | 0.00 | |
| Series B Convertible Preferred Stock Direct | Common Stock31.37K shares | 10/13/2026 | C · Conversion | −31.37K | — | 0.00 |